Acasă › Cancer pulmonar cu celule non-pătrate › California › Roseville
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Roseville, CA
10 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Roseville (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Kaiser Permanente-Roseville, Roseville
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Sutter Institute for Medical Research, Roseville
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Kaiser Permanente-Roseville, Roseville
- Sutter Roseville Medical Center, Roseville
- Sutter Auburn Faith Hospital, Auburn · La 15 mi distanță
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Roseville Medical Plaza Care Center, Roseville
- Sutter Medical Center, Sacramento Infusion Center at Roseville, Roseville
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
În curs de recrutareFaza 3
- Sutter Health, Roseville
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Kaiser Permanente-Roseville, Roseville
- Sutter Roseville Medical Center, Roseville
- Sutter Auburn Faith Hospital, Auburn · La 15 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Sutter Roseville Medical Center, Roseville
- Sutter Auburn Faith Hospital, Auburn · La 15 mi distanță
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Kaiser Permanente-Roseville, Roseville
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Sutter Roseville Medical Center, Roseville
- Sutter Auburn Faith Hospital, Auburn · La 15 mi distanță
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Kaiser Permanente-Roseville, Roseville
- Mercy Cancer Center - Rocklin, Rocklin · La 4 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Roseville
- Cancer pulmonar9 studii
- Cancer de prostată8 studii
- Cancer de sân7 studii
- Cancer colorectal6 studii
- Leucemie mieloasă acută5 studii
- Diabet de tip 25 studii
- Cancer de colon5 studii
- Cancer renal (carcinom cu celule renale)4 studii
- Cancer (toate tipurile)4 studii
- Cancer ovarian3 studii
- Cancer rectal3 studii
- Melanom3 studii
Sursă: ClinicalTrials.gov, date preluate la 7 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.